精神障害薬の世界市場（～2026年）

• 英文タイトル：Global Mental Disorders Drugs Market Insights and Forecast to 2026

• レポートコード：MRC2-11QY07614 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料は精神障害薬のグローバル市場について調査・分析したレポートです。種類別（統合失調症薬、抗うつ薬、抗精神病薬、抗不安薬、物質・アルコール中毒治療薬、小児・青年期精神障害薬、認知障害治療薬、睡眠障害、その他）市場規模、用途別（子供、青年、大人）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別精神障害薬の競争状況、市場シェア ・世界の精神障害薬市場：種類別市場規模 2015年-2020年（統合失調症薬、抗うつ薬、抗精神病薬、抗不安薬、物質・アルコール中毒治療薬、小児・青年期精神障害薬、認知障害治療薬、睡眠障害、その他） ・世界の精神障害薬市場：種類別市場規模予測 2021年-2026年（統合失調症薬、抗うつ薬、抗精神病薬、抗不安薬、物質・アルコール中毒治療薬、小児・青年期精神障害薬、認知障害治療薬、睡眠障害、その他） ・世界の精神障害薬市場：用途別市場規模 2015年-2020年（子供、青年、大人） ・世界の精神障害薬市場：用途別市場規模予測 2021年-2026年（子供、青年、大人） ・北米の精神障害薬市場分析：米国、カナダ ・ヨーロッパの精神障害薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの精神障害薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の精神障害薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの精神障害薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Johnson and Johnson、Pfizer、Eli Lilly、GlaxoSmithKline、AstraZeneca、Bristol-Myers Squibb ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

Market Analysis and Insights: Global Mental Disorders Drugs Market
The global Mental Disorders Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Mental Disorders Drugs Scope and Market Size
Mental Disorders Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Mental Disorders Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Mental Disorders Drugs market is segmented into
Drugs for Schizophrenia
Antidepressants
Antipsychotics
Anxiolytics
Drugs for the Treatment of Substance and Alcohol Addiction
Drugs for Childhood and Adolescent Mental Illness
Drugs to Treat Cognitive Disorders
Sleep Disorders
Others

Segment by Application, the Mental Disorders Drugs market is segmented into
Children
Adolescents
Adults

Regional and Country-level Analysis
The Mental Disorders Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Mental Disorders Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Mental Disorders Drugs Market Share Analysis
Mental Disorders Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Mental Disorders Drugs business, the date to enter into the Mental Disorders Drugs market, Mental Disorders Drugs product introduction, recent developments, etc.

The major vendors covered:
Johnson and Johnson
Pfizer
Eli Lilly
GlaxoSmithKline
AstraZeneca
Bristol-Myers Squibb
…

レポート目次

---

1 Study Coverage
1.1 Mental Disorders Drugs Product Introduction
1.2 Market Segments
1.3 Key Mental Disorders Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Mental Disorders Drugs Market Size Growth Rate by Type
1.4.2 Drugs for Schizophrenia
1.4.3 Antidepressants
1.4.4 Antipsychotics
1.4.5 Anxiolytics
1.4.6 Drugs for the Treatment of Substance and Alcohol Addiction
1.4.7 Drugs for Childhood and Adolescent Mental Illness
1.4.8 Drugs to Treat Cognitive Disorders
1.4.9 Sleep Disorders
1.4.10 Others
1.5 Market by Application
1.5.1 Global Mental Disorders Drugs Market Size Growth Rate by Application
1.5.2 Children
1.5.3 Adolescents
1.5.4 Adults
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Mental Disorders Drugs Market Size, Estimates and Forecasts
2.1.1 Global Mental Disorders Drugs Revenue 2015-2026
2.1.2 Global Mental Disorders Drugs Sales 2015-2026
2.2 Global Mental Disorders Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Mental Disorders Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Mental Disorders Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Mental Disorders Drugs Competitor Landscape by Players
3.1 Mental Disorders Drugs Sales by Manufacturers
3.1.1 Mental Disorders Drugs Sales by Manufacturers (2015-2020)
3.1.2 Mental Disorders Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Mental Disorders Drugs Revenue by Manufacturers
3.2.1 Mental Disorders Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Mental Disorders Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Mental Disorders Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Mental Disorders Drugs Revenue in 2019
3.2.5 Global Mental Disorders Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Mental Disorders Drugs Price by Manufacturers
3.4 Mental Disorders Drugs Manufacturing Base Distribution, Product Types
3.4.1 Mental Disorders Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Mental Disorders Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Mental Disorders Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Mental Disorders Drugs Market Size by Type (2015-2020)
4.1.1 Global Mental Disorders Drugs Sales by Type (2015-2020)
4.1.2 Global Mental Disorders Drugs Revenue by Type (2015-2020)
4.1.3 Mental Disorders Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Mental Disorders Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Mental Disorders Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Mental Disorders Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Mental Disorders Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Mental Disorders Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Mental Disorders Drugs Market Size by Application (2015-2020)
5.1.1 Global Mental Disorders Drugs Sales by Application (2015-2020)
5.1.2 Global Mental Disorders Drugs Revenue by Application (2015-2020)
5.1.3 Mental Disorders Drugs Price by Application (2015-2020)
5.2 Mental Disorders Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Mental Disorders Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Mental Disorders Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Mental Disorders Drugs Price Forecast by Application (2021-2026)

6 North America
6.1 North America Mental Disorders Drugs by Country
6.1.1 North America Mental Disorders Drugs Sales by Country
6.1.2 North America Mental Disorders Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Mental Disorders Drugs Market Facts & Figures by Type
6.3 North America Mental Disorders Drugs Market Facts & Figures by Application

7 Europe
7.1 Europe Mental Disorders Drugs by Country
7.1.1 Europe Mental Disorders Drugs Sales by Country
7.1.2 Europe Mental Disorders Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Mental Disorders Drugs Market Facts & Figures by Type
7.3 Europe Mental Disorders Drugs Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Mental Disorders Drugs by Region
8.1.1 Asia Pacific Mental Disorders Drugs Sales by Region
8.1.2 Asia Pacific Mental Disorders Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Mental Disorders Drugs Market Facts & Figures by Type
8.3 Asia Pacific Mental Disorders Drugs Market Facts & Figures by Application

9 Latin America
9.1 Latin America Mental Disorders Drugs by Country
9.1.1 Latin America Mental Disorders Drugs Sales by Country
9.1.2 Latin America Mental Disorders Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Mental Disorders Drugs Market Facts & Figures by Type
9.3 Central & South America Mental Disorders Drugs Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Mental Disorders Drugs by Country
10.1.1 Middle East and Africa Mental Disorders Drugs Sales by Country
10.1.2 Middle East and Africa Mental Disorders Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Mental Disorders Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Mental Disorders Drugs Market Facts & Figures by Application

11 Company Profiles
11.1 Johnson and Johnson
11.1.1 Johnson and Johnson Corporation Information
11.1.2 Johnson and Johnson Description and Business Overview
11.1.3 Johnson and Johnson Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Johnson and Johnson Mental Disorders Drugs Products Offered
11.1.5 Johnson and Johnson Related Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Description and Business Overview
11.2.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Pfizer Mental Disorders Drugs Products Offered
11.2.5 Pfizer Related Developments
11.3 Eli Lilly
11.3.1 Eli Lilly Corporation Information
11.3.2 Eli Lilly Description and Business Overview
11.3.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Eli Lilly Mental Disorders Drugs Products Offered
11.3.5 Eli Lilly Related Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Corporation Information
11.4.2 GlaxoSmithKline Description and Business Overview
11.4.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.4.4 GlaxoSmithKline Mental Disorders Drugs Products Offered
11.4.5 GlaxoSmithKline Related Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Corporation Information
11.5.2 AstraZeneca Description and Business Overview
11.5.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.5.4 AstraZeneca Mental Disorders Drugs Products Offered
11.5.5 AstraZeneca Related Developments
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Corporation Information
11.6.2 Bristol-Myers Squibb Description and Business Overview
11.6.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Bristol-Myers Squibb Mental Disorders Drugs Products Offered
11.6.5 Bristol-Myers Squibb Related Developments
11.1 Johnson and Johnson
11.1.1 Johnson and Johnson Corporation Information
11.1.2 Johnson and Johnson Description and Business Overview
11.1.3 Johnson and Johnson Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Johnson and Johnson Mental Disorders Drugs Products Offered
11.1.5 Johnson and Johnson Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Mental Disorders Drugs Market Estimates and Projections by Region
12.1.1 Global Mental Disorders Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Mental Disorders Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Mental Disorders Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Mental Disorders Drugs Sales Forecast (2021-2026)
12.2.2 North America: Mental Disorders Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Mental Disorders Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Mental Disorders Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Mental Disorders Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Mental Disorders Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Mental Disorders Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Mental Disorders Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Mental Disorders Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Mental Disorders Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Mental Disorders Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Mental Disorders Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Mental Disorders Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Mental Disorders Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Mental Disorders Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Mental Disorders Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Mental Disorders Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Mental Disorders Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Mental Disorders Drugs Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Mental Disorders Drugs Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Mental Disorders Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Mental Disorders Drugs Market Segments
Table 2. Ranking of Global Top Mental Disorders Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Mental Disorders Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Drugs for Schizophrenia
Table 5. Major Manufacturers of Antidepressants
Table 6. Major Manufacturers of Antipsychotics
Table 7. Major Manufacturers of Anxiolytics
Table 8. Major Manufacturers of Drugs for the Treatment of Substance and Alcohol Addiction
Table 9. Major Manufacturers of Drugs for Childhood and Adolescent Mental Illness
Table 10. Major Manufacturers of Drugs to Treat Cognitive Disorders
Table 11. Major Manufacturers of Sleep Disorders
Table 12. Major Manufacturers of Others
Table 13. Global Mental Disorders Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 14. Global Mental Disorders Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 15. Global Mental Disorders Drugs Sales by Regions 2015-2020 (K Units)
Table 16. Global Mental Disorders Drugs Sales Market Share by Regions (2015-2020)
Table 17. Global Mental Disorders Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 18. Global Mental Disorders Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 19. Global Mental Disorders Drugs Sales Share by Manufacturers (2015-2020)
Table 20. Global Mental Disorders Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 21. Global Mental Disorders Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mental Disorders Drugs as of 2019)
Table 22. Mental Disorders Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 23. Mental Disorders Drugs Revenue Share by Manufacturers (2015-2020)
Table 24. Key Manufacturers Mental Disorders Drugs Price (2015-2020) (USD/Pcs)
Table 25. Mental Disorders Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Mental Disorders Drugs Product Type
Table 27. Date of International Manufacturers Enter into Mental Disorders Drugs Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Mental Disorders Drugs Sales by Type (2015-2020) (K Units)
Table 30. Global Mental Disorders Drugs Sales Share by Type (2015-2020)
Table 31. Global Mental Disorders Drugs Revenue by Type (2015-2020) (US$ Million)
Table 32. Global Mental Disorders Drugs Revenue Share by Type (2015-2020)
Table 33. Mental Disorders Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 34. Global Mental Disorders Drugs Sales by Application (2015-2020) (K Units)
Table 35. Global Mental Disorders Drugs Sales Share by Application (2015-2020)
Table 36. North America Mental Disorders Drugs Sales by Country (2015-2020) (K Units)
Table 37. North America Mental Disorders Drugs Sales Market Share by Country (2015-2020)
Table 38. North America Mental Disorders Drugs Revenue by Country (2015-2020) (US$ Million)
Table 39. North America Mental Disorders Drugs Revenue Market Share by Country (2015-2020)
Table 40. North America Mental Disorders Drugs Sales by Type (2015-2020) (K Units)
Table 41. North America Mental Disorders Drugs Sales Market Share by Type (2015-2020)
Table 42. North America Mental Disorders Drugs Sales by Application (2015-2020) (K Units)
Table 43. North America Mental Disorders Drugs Sales Market Share by Application (2015-2020)
Table 44. Europe Mental Disorders Drugs Sales by Country (2015-2020) (K Units)
Table 45. Europe Mental Disorders Drugs Sales Market Share by Country (2015-2020)
Table 46. Europe Mental Disorders Drugs Revenue by Country (2015-2020) (US$ Million)
Table 47. Europe Mental Disorders Drugs Revenue Market Share by Country (2015-2020)
Table 48. Europe Mental Disorders Drugs Sales by Type (2015-2020) (K Units)
Table 49. Europe Mental Disorders Drugs Sales Market Share by Type (2015-2020)
Table 50. Europe Mental Disorders Drugs Sales by Application (2015-2020) (K Units)
Table 51. Europe Mental Disorders Drugs Sales Market Share by Application (2015-2020)
Table 52. Asia Pacific Mental Disorders Drugs Sales by Region (2015-2020) (K Units)
Table 53. Asia Pacific Mental Disorders Drugs Sales Market Share by Region (2015-2020)
Table 54. Asia Pacific Mental Disorders Drugs Revenue by Region (2015-2020) (US$ Million)
Table 55. Asia Pacific Mental Disorders Drugs Revenue Market Share by Region (2015-2020)
Table 56. Asia Pacific Mental Disorders Drugs Sales by Type (2015-2020) (K Units)
Table 57. Asia Pacific Mental Disorders Drugs Sales Market Share by Type (2015-2020)
Table 58. Asia Pacific Mental Disorders Drugs Sales by Application (2015-2020) (K Units)
Table 59. Asia Pacific Mental Disorders Drugs Sales Market Share by Application (2015-2020)
Table 60. Latin America Mental Disorders Drugs Sales by Country (2015-2020) (K Units)
Table 61. Latin America Mental Disorders Drugs Sales Market Share by Country (2015-2020)
Table 62. Latin Americaa Mental Disorders Drugs Revenue by Country (2015-2020) (US$ Million)
Table 63. Latin America Mental Disorders Drugs Revenue Market Share by Country (2015-2020)
Table 64. Latin America Mental Disorders Drugs Sales by Type (2015-2020) (K Units)
Table 65. Latin America Mental Disorders Drugs Sales Market Share by Type (2015-2020)
Table 66. Latin America Mental Disorders Drugs Sales by Application (2015-2020) (K Units)
Table 67. Latin America Mental Disorders Drugs Sales Market Share by Application (2015-2020)
Table 68. Middle East and Africa Mental Disorders Drugs Sales by Country (2015-2020) (K Units)
Table 69. Middle East and Africa Mental Disorders Drugs Sales Market Share by Country (2015-2020)
Table 70. Middle East and Africa Mental Disorders Drugs Revenue by Country (2015-2020) (US$ Million)
Table 71. Middle East and Africa Mental Disorders Drugs Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Mental Disorders Drugs Sales by Type (2015-2020) (K Units)
Table 73. Middle East and Africa Mental Disorders Drugs Sales Market Share by Type (2015-2020)
Table 74. Middle East and Africa Mental Disorders Drugs Sales by Application (2015-2020) (K Units)
Table 75. Middle East and Africa Mental Disorders Drugs Sales Market Share by Application (2015-2020)
Table 76. Johnson and Johnson Corporation Information
Table 77. Johnson and Johnson Description and Major Businesses
Table 78. Johnson and Johnson Mental Disorders Drugs Production (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 79. Johnson and Johnson Product
Table 80. Johnson and Johnson Recent Development
Table 81. Pfizer Corporation Information
Table 82. Pfizer Description and Major Businesses
Table 83. Pfizer Mental Disorders Drugs Production (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 84. Pfizer Product
Table 85. Pfizer Recent Development
Table 86. Eli Lilly Corporation Information
Table 87. Eli Lilly Description and Major Businesses
Table 88. Eli Lilly Mental Disorders Drugs Production (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 89. Eli Lilly Product
Table 90. Eli Lilly Recent Development
Table 91. GlaxoSmithKline Corporation Information
Table 92. GlaxoSmithKline Description and Major Businesses
Table 93. GlaxoSmithKline Mental Disorders Drugs Production (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 94. GlaxoSmithKline Product
Table 95. GlaxoSmithKline Recent Development
Table 96. AstraZeneca Corporation Information
Table 97. AstraZeneca Description and Major Businesses
Table 98. AstraZeneca Mental Disorders Drugs Production (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 99. AstraZeneca Product
Table 100. AstraZeneca Recent Development
Table 101. Bristol-Myers Squibb Corporation Information
Table 102. Bristol-Myers Squibb Description and Major Businesses
Table 103. Bristol-Myers Squibb Mental Disorders Drugs Production (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 104. Bristol-Myers Squibb Product
Table 105. Bristol-Myers Squibb Recent Development
Table 106. Global Mental Disorders Drugs Sales Forecast by Regions (2021-2026) (K Units)
Table 107. Global Mental Disorders Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 108. Global Mental Disorders Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 109. Global Mental Disorders Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 110. North America: Mental Disorders Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 111. North America: Mental Disorders Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 112. Europe: Mental Disorders Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 113. Europe: Mental Disorders Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 114. Asia Pacific: Mental Disorders Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 115. Asia Pacific: Mental Disorders Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 116. Latin America: Mental Disorders Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 117. Latin America: Mental Disorders Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 118. Middle East and Africa: Mental Disorders Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 119. Middle East and Africa: Mental Disorders Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 120. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 121. Key Challenges
Table 122. Market Risks
Table 123. Main Points Interviewed from Key Mental Disorders Drugs Players
Table 124. Mental Disorders Drugs Customers List
Table 125. Mental Disorders Drugs Distributors List
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Mental Disorders Drugs Product Picture
Figure 2. Global Mental Disorders Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Drugs for Schizophrenia Product Picture
Figure 4. Antidepressants Product Picture
Figure 5. Antipsychotics Product Picture
Figure 6. Anxiolytics Product Picture
Figure 7. Drugs for the Treatment of Substance and Alcohol Addiction Product Picture
Figure 8. Drugs for Childhood and Adolescent Mental Illness Product Picture
Figure 9. Drugs to Treat Cognitive Disorders Product Picture
Figure 10. Sleep Disorders Product Picture
Figure 11. Others Product Picture
Figure 12. Global Mental Disorders Drugs Sales Market Share by Application in 2020 & 2026
Figure 13. Children
Figure 14. Adolescents
Figure 15. Adults
Figure 16. Mental Disorders Drugs Report Years Considered
Figure 17. Global Mental Disorders Drugs Market Size 2015-2026 (US$ Million)
Figure 18. Global Mental Disorders Drugs Sales 2015-2026 (K Units)
Figure 19. Global Mental Disorders Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 20. Global Mental Disorders Drugs Sales Market Share by Region (2015-2020)
Figure 21. Global Mental Disorders Drugs Sales Market Share by Region in 2019
Figure 22. Global Mental Disorders Drugs Revenue Market Share by Region (2015-2020)
Figure 23. Global Mental Disorders Drugs Revenue Market Share by Region in 2019
Figure 24. Global Mental Disorders Drugs Sales Share by Manufacturer in 2019
Figure 25. The Top 10 and 5 Players Market Share by Mental Disorders Drugs Revenue in 2019
Figure 26. Mental Disorders Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Mental Disorders Drugs Sales Market Share by Type (2015-2020)
Figure 28. Global Mental Disorders Drugs Sales Market Share by Type in 2019
Figure 29. Global Mental Disorders Drugs Revenue Market Share by Type (2015-2020)
Figure 30. Global Mental Disorders Drugs Revenue Market Share by Type in 2019
Figure 31. Global Mental Disorders Drugs Market Share by Price Range (2015-2020)
Figure 32. Global Mental Disorders Drugs Sales Market Share by Application (2015-2020)
Figure 33. Global Mental Disorders Drugs Sales Market Share by Application in 2019
Figure 34. Global Mental Disorders Drugs Revenue Market Share by Application (2015-2020)
Figure 35. Global Mental Disorders Drugs Revenue Market Share by Application in 2019
Figure 36. North America Mental Disorders Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 37. North America Mental Disorders Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 38. North America Mental Disorders Drugs Sales Market Share by Country in 2019
Figure 39. North America Mental Disorders Drugs Revenue Market Share by Country in 2019
Figure 40. U.S. Mental Disorders Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 41. U.S. Mental Disorders Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Canada Mental Disorders Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 43. Canada Mental Disorders Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. North America Mental Disorders Drugs Market Share by Type in 2019
Figure 45. North America Mental Disorders Drugs Market Share by Application in 2019
Figure 46. Europe Mental Disorders Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 47. Europe Mental Disorders Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 48. Europe Mental Disorders Drugs Sales Market Share by Country in 2019
Figure 49. Europe Mental Disorders Drugs Revenue Market Share by Country in 2019
Figure 50. Germany Mental Disorders Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 51. Germany Mental Disorders Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. France Mental Disorders Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 53. France Mental Disorders Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. U.K. Mental Disorders Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 55. U.K. Mental Disorders Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Italy Mental Disorders Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 57. Italy Mental Disorders Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Russia Mental Disorders Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 59. Russia Mental Disorders Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Europe Mental Disorders Drugs Market Share by Type in 2019
Figure 61. Europe Mental Disorders Drugs Market Share by Application in 2019
Figure 62. Asia Pacific Mental Disorders Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 63. Asia Pacific Mental Disorders Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 64. Asia Pacific Mental Disorders Drugs Sales Market Share by Region in 2019
Figure 65. Asia Pacific Mental Disorders Drugs Revenue Market Share by Region in 2019
Figure 66. China Mental Disorders Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 67. China Mental Disorders Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Japan Mental Disorders Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 69. Japan Mental Disorders Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. South Korea Mental Disorders Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 71. South Korea Mental Disorders Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. India Mental Disorders Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 73. India Mental Disorders Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Australia Mental Disorders Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 75. Australia Mental Disorders Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Taiwan Mental Disorders Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 77. Taiwan Mental Disorders Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Indonesia Mental Disorders Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 79. Indonesia Mental Disorders Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Thailand Mental Disorders Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 81. Thailand Mental Disorders Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Malaysia Mental Disorders Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 83. Malaysia Mental Disorders Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Philippines Mental Disorders Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 85. Philippines Mental Disorders Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Vietnam Mental Disorders Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 87. Vietnam Mental Disorders Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Asia Pacific Mental Disorders Drugs Market Share by Type in 2019
Figure 89. Asia Pacific Mental Disorders Drugs Market Share by Application in 2019
Figure 90. Latin America Mental Disorders Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 91. Latin America Mental Disorders Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 92. Latin America Mental Disorders Drugs Sales Market Share by Country in 2019
Figure 93. Latin America Mental Disorders Drugs Revenue Market Share by Country in 2019
Figure 94. Mexico Mental Disorders Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 95. Mexico Mental Disorders Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Brazil Mental Disorders Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 97. Brazil Mental Disorders Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Argentina Mental Disorders Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 99. Argentina Mental Disorders Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Latin America Mental Disorders Drugs Market Share by Type in 2019
Figure 101. Latin America Mental Disorders Drugs Market Share by Application in 2019
Figure 102. Middle East and Africa Mental Disorders Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 103. Middle East and Africa Mental Disorders Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 104. Middle East and Africa Mental Disorders Drugs Sales Market Share by Country in 2019
Figure 105. Middle East and Africa Mental Disorders Drugs Revenue Market Share by Country in 2019
Figure 106. Turkey Mental Disorders Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 107. Turkey Mental Disorders Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Saudi Arabia Mental Disorders Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 109. Saudi Arabia Mental Disorders Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. U.A.E Mental Disorders Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 111. U.A.E Mental Disorders Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 112. Middle East and Africa Mental Disorders Drugs Market Share by Type in 2019
Figure 113. Middle East and Africa Mental Disorders Drugs Market Share by Application in 2019
Figure 114. North America Mental Disorders Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. North America Mental Disorders Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Europe Mental Disorders Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Europe Mental Disorders Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Asia Pacific Mental Disorders Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 119. Asia Pacific Mental Disorders Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Latin America Mental Disorders Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 121. Latin America Mental Disorders Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Middle East and Africa Mental Disorders Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 123. Middle East and Africa Mental Disorders Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Porter's Five Forces Analysis
Figure 125. Channels of Distribution
Figure 126. Distributors Profiles
Figure 127. Bottom-up and Top-down Approaches for This Report
Figure 128. Data Triangulation
Figure 129. Key Executives Interviewed

---